Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rasmus W Licht

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Bipolar Disorders|December 14, 2002
Limits of the applicability and generalizability of drug trials in maniaRasmus W Licht
Lancet (London, England)|January 23, 2010
A new BALANCE in bipolar I disorderRasmus W Licht
CNS Neuroscience & Therapeutics|November 11, 2011
Lithium: still a major option in the management of bipolar disorderRasmus W Licht
Journal of Affective Disorders|February 13, 2013
Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5)Rasmus W Licht,
The American Journal of Psychiatry|December 7, 2005
Why the Hamilton Depression Rating Scale enduresRasmus W Licht, Per Bech
Psychopharmacology|May 1, 2002
Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentationRasmus W Licht, Susanne Qvitzau
Ugeskrift for Laeger|May 25, 2002
[Psychopharmacological treatment of bipolar disease]Rasmus W Licht, Per Vestergaard
Bipolar Disorders|January 27, 2024
A comment and correctionRasmus W Licht, René E Nielsen
Bjpsych Open|October 12, 2023
The true effect of lithium is hard to determineRené Ernst Nielsen, Rasmus W Licht
Bipolar Disorders|December 27, 2023
Invited commentary to Professor Belmaker's letter on lithium treatment for bipolar disorderRasmus W Licht, René E Nielsen
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Bipolar Disorders|December 14, 2002
Limits of the applicability and generalizability of drug trials in maniaRasmus W Licht
Lancet (London, England)|January 23, 2010
A new BALANCE in bipolar I disorderRasmus W Licht
CNS Neuroscience & Therapeutics|November 11, 2011
Lithium: still a major option in the management of bipolar disorderRasmus W Licht
Journal of Affective Disorders|February 13, 2013
Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5)Rasmus W Licht,
The American Journal of Psychiatry|December 7, 2005
Why the Hamilton Depression Rating Scale enduresRasmus W Licht, Per Bech
Psychopharmacology|May 1, 2002
Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentationRasmus W Licht, Susanne Qvitzau
Ugeskrift for Laeger|May 25, 2002
[Psychopharmacological treatment of bipolar disease]Rasmus W Licht, Per Vestergaard
Bipolar Disorders|January 27, 2024
A comment and correctionRasmus W Licht, René E Nielsen
Bjpsych Open|October 12, 2023
The true effect of lithium is hard to determineRené Ernst Nielsen, Rasmus W Licht
Bipolar Disorders|December 27, 2023
Invited commentary to Professor Belmaker's letter on lithium treatment for bipolar disorderRasmus W Licht, René E Nielsen
Pageof 8